首页 > 市场调查报告书 > 医疗设备

体外诊断生技设备

市场调查报告书

商品编码

1736849

2026 年至 2032 年聚合酵素链锁反应(PCR) 市场（按产品、应用、最终用户和地区）

Polymerase Chain Reaction PCR Market By Product (Instruments, Reagents & Consumables), Application (Clinical Diagnostics, Life Sciences), End User (Clinical Diagnostics Labs, Research Institutions, Pharmaceutical Companies), & Region for 2026-2032

出版日期: 2025年05月07日 | 出版商:

Verified Market Research | 英文 202 Pages | 商品交期: 2-3个工作天内

价格

简介目录

聚合酵素链锁反应（PCR）市场 2026-2032

感染疾病负担的增加、个人化医疗革命、基因组研究和癌症诊断的蓬勃发展以及医疗保健领域的监测因此，感染疾病负担的增加、个性化医疗革命、基因组研究和癌症诊断的蓬勃发展以及医疗保健领域的监测将成倍地推动市场规模的增长，到 2024 年将超过 109.5 亿美元，到 2032 年达到 203.2 亿美元的估值。

随着法医学的进步，开发中国家和小型产业正日益普及，因为它们能够从微小的犯罪现场样本中进行DNA分析。因此，法医学的进步在新兴国家日益普及，推动市场在2026年至2032年间的复合年增长率达到6.50%。

聚合酵素链锁反应（PCR）市场：定义/概述

聚合酵素链锁反应(PCR) 被认为是一项突破性技术，它能够从微小的 DNA 样本中产生数百万个拷贝，就像放大海滩上的一粒沙子一样。 PCR 不仅可以检测每一粒沙子，还能产生数百万个相同的拷贝，以便进行全面的分析。

PCR 过程涉及一系列严格控制的步骤。首先，分离目标 DNA，加热将双螺旋结构分离成单链。然后引入引子（设计用于匹配目标区域起始和终止位置的特定 DNA 片段）。之后，使用一种称为 DNA聚合酵素的酵素。

对快速诊断测试的需求不断增长以及 PCR 技术的日益普及将如何影响聚合酵素链锁反应(PCR) 市场的成长？

快速诊断检测需求的不断增长以及PCR技术的日益普及是聚合酵素链锁反应(PCR)市场成长的主要原因。 PCR技术因其高准确度、自动化、精密度、即时定量和高灵敏度等特点，正日益广泛采用。 qPCR技术能够提供广泛的核酸输入，使其成为一项实用且极具价值的研究应用技术。它在肿瘤学和遗传疾病研究、干细胞研究、病原体检测、感染疾病研究、药物基因组学、药物分析、农业生物技术和植物科学研究等领域有着广泛的应用。此外，它在法医学领域也得到了广泛的应用。

阿兹海默症、透纳氏症、帕金森氏症等慢性病、感染疾病疾病和遗传疾病的发生率不断上升。此外，先天性心臟疾病患者的数量正在增加，需要医疗专业人员使用分子诊断工具进行准确诊断。由于不健康饮食、肥胖、大量烟酒消费和久坐的生活方式，癌症发病率预计会增加。据世界卫生组织欧洲区域主任称，在冠状病毒感染患者中，每 10 例死亡病例中就有 8 例是患有心血管疾病/高血压、糖尿病和其他慢性潜在疾病的患者。 SARS-CoV-2 大流行推动了对 qPCR 仪器和耗材的需求。预计 COVID-19 发病率的上升将导致预防性筛检激增，从而推动市场成长。

新兴国家QPCR设备的高成本将如何阻碍聚合酵素链锁反应（PCR）市场的成长？

qPCR 仪器的高成本阻碍了聚合酵素链锁反应(PCR) 市场的成长。据报导，Bio-Rad Laboratories 的 CFX Connect PCR 检测系统售价约为 17,995 美元。相较之下，赛默飞世尔科技的 7,900 HT qPCR 系统售价为 2 万至 3 万美元。数位 PCR 仪器以其更精准的结果和更高的灵敏度而闻名，其价格高于即时PCR仪器。手动 dPCR 仪器的价格估计为 6.5 万至 7 万美元，而自动化 dPCR 仪器的价格则接近 10 万美元。

此外，样本製备或 PCR 过程中的污染已得到公认，可能导致假阳性结果，这在各种应用中，尤其是在诊断环境中，可能产生重大影响。污染源多种多样，包括环境 DNA、样本间的交叉污染以及先前 PCR 反应的残留物。要缓解这些问题，需要实施完善的方案、聘用训练有素的人员并持续进行品管措施。这些措施包括使用专用 PCR 工作站、对设备进行紫外线消毒以及在每次 PCR 运行中设定阴性对照。

The increase in infectious disease burden, personalized medicine revolution, genomics research boom & cancer diagnostics and monitoring in the healthcare sector. Thus, the growing infectious disease burden, personalized medicine revolution, genomics research boom & cancer diagnostics, and monitoring in the healthcare sector surge the growth of market size surpassing USD 10.95 Billion in 2024 to reach the valuation of USD 17.32 Billion by 2032.

Forensic science advancements are becoming more and more popular in developing countries and small-scale industries due to DNA profiling from minuscule crime scene samples. Thus, forensic science advancements are gaining popularity in emerging countries enabling the market to grow at a CAGR of 6.50% from 2026 to 2032.

Polymerase Chain Reaction PCR Market: Definition/ Overview

The Polymerase Chain Reaction (PCR) is considered a groundbreaking technique by which millions of copies can be generated from a minuscule DNA sample. An analogy can be drawn to magnifying a single grain of sand on a beach. Through PCR, not only can that individual grain be scrutinized, but millions of identical replicas can also be produced, enabling comprehensive analysis.

A series of meticulously controlled steps is involved in the PCR process. Initially, the target DNA is isolated and subjected to heat, causing the double helix to be separated into single strands. Primers, which are specific DNA fragments designed to match the target region's beginning and end, are then introduced. Subsequently, an enzyme known as DNA polymerase is employed.

How do the Increasing Demand for Rapid Diagnostic Tests and Growing Adoption of PCR Technologies have any Implications for the Growth of the Polymerase Chain Reaction PCR Market?

The increase in demand for rapid diagnostic tests and the growing adoption of PCR technologies are the dominant reasons for the growth of the polymerase chain reaction PCR market. PCR techniques are being increasingly adopted due to their accuracy, automation, precision, real-time quantification, and sensitivity. A wide range of input nucleic acids is offered by qPCR, making it a practical and valuable technology in research applications. Diverse applications are found in areas such as oncology & genetic disease research, stem cell research, pathogen detection, research of infectious diseases, pharmacogenomics, pharmaceutical analytics, agricultural biotechnology, and plant sciences research. It is also significantly used in forensic sciences.

The increase in the prevalence of chronic & infectious diseases and genetic disorders, such as Alzheimer's disease, Turner syndrome, & Parkinson's disease. Furthermore, the number of patients with congenital heart disease is increasing, necessitating the use of molecular diagnostic tools by medical professionals for accurate diagnoses. Cancer prevalence is expected to be increased by unhealthy dietary habits, obesity, high tobacco & alcohol consumption, and a sedentary lifestyle. According to WHO Regional Director for Europe, 8 out of 10 deaths in coronavirus-infected patients were suffered by those with cardiovascular diseases/hypertension, diabetes, and other chronic underlying conditions. The demand for qPCR equipment and consumables is being driven by the SARS-CoV-2 pandemic. A surge in preventive screenings is expected to be prompted by the increasing incidence of COVID-19, facilitating market growth.

How Does the High QPCR Device Costs in Emerging Countries Impede the Growth of the Polymerase Chain Reaction PCR Market?

The high QPCR device costs hinder the growth of the polymerase chain reaction PCR market. It is reported that the CFX Connect PCR Detection System by Bio-Rad Laboratories is priced at approximately USD 17,995. In comparison, Thermo Fisher Scientific's 7900 HT qPCR system is found to be priced between USD 20,000 and USD 30,000. Digital PCR instruments, which are known for more accurate results and sensitivity, are priced higher than real-time PCR instruments. The cost of a manual dPCR instrument is estimated to be between USD 65,000 and USD 70,000, while automated dPCR instruments can be priced at nearly USD 100,000.

Furthermore, it has been recognized that contamination during sample preparation or the PCR process can lead to false positive results, which can have significant implications in various applications, particularly in diagnostic settings. The sources of contamination are diverse and can include environmental DNA, cross-contamination between samples, or carryover from previous PCR reactions. It is understood that mitigating these issues requires the implementation of robust protocols, the employment of well-trained personnel, and the maintenance of ongoing quality control measures. These measures may include the use of dedicated PCR workstations, UV sterilization of equipment, and the inclusion of negative controls in each PCR run.

Category-Wise Acumens

How Do the Well-Surface Characteristics, And Material Properties Foster the Growth of the Consumables & Reagents Segment?

The consumable & reagents segment dominates in the polymerase chain reaction market. The well-surface characteristics of PCR consumables are being recognized as a critical factor in the segment's growth. It is understood that the surface properties of the wells can significantly impact the efficiency of DNA amplification. Surfaces that are optimized for DNA binding and release are being developed, which is contributing to improved PCR results. Furthermore, it has been noted that different surface treatments are being applied to enhance the compatibility of consumables with various sample types and PCR chemistries.

Material properties of PCR consumables are also being identified as a key driver of the segment's expansion. It is being reported that manufacturers are focusing on developing materials that offer superior heat conductivity and thermal stability. These properties are essential for ensuring rapid and uniform temperature changes during PCR cycles. Furthermore, materials that minimize evaporation and prevent sample loss are being increasingly adopted, which is leading to more consistent and reliable results.

How Do the Disciplines of Personalized Medicine and Genomics Research in the Healthcare Sector Surge the Growth of the Clinical Diagnostics Segment?

The clinical diagnostic segment dominates the polymerase chain reaction market. The growth of the clinical diagnostics segment is being significantly propelled by the rapidly evolving disciplines of personalized medicine and genomics research in the healthcare sector. It is observed that PCR techniques are being increasingly relied upon for crucial activities such as gene analysis and variation detection within these fields. As advancements are made in personalized medicine and genomics, a corresponding surge in the demand for PCR applications is being witnessed in the life sciences sector. The role of PCR in routine diagnostics is being further solidified by the rising burden of infectious diseases, which is contributing to its increased adoption. While both clinical diagnostics and life sciences applications are expected to make substantial contributions to market growth, it is anticipated that clinical diagnostics may hold a slight advantage in the near term due to its established position in routine testing protocols. However, it is projected that the life sciences segment has the potential to emerge as the dominant application in the long run, driven by its association with cutting-edge research and progress in personalized care approaches.

Country/Region-wise Acumens

How the Well-developed Healthcare System Surges the Growth of the Polymerase Chain Reaction PCR Market in North America?

North America is the dominating region in the polymerase chain reaction (PCR) market. The strong market presence in North America is attributed to well-developed healthcare systems, which are characterized by high levels of research funding and access to advanced technologies. A strong understanding of PCR applications is often observed among the general public and healthcare professionals in North America, which is leading to greater demand for diagnostic tests and research tools. Strict guidelines for diagnostic tests and medical devices are enforced by regulatory bodies in North America. This emphasis on quality ensures accuracy and reliability, thereby driving market growth through the adoption of advanced PCR instruments and assays. As a result of these factors, North America's position as the dominant force in the PCR market is being solidified.

How does the Focus on Innovation Foster the Growth of the Polymerase Chain Reaction PCR Market in Europe?

Europe is the fastest-growing region in the polymerase chain reaction (PCR) market during the forecast period characterized by a mature market landscape where innovation is highly prioritized. A significant number of leading research institutions are housed in Europe, where heavy reliance on PCR for various applications in life sciences is observed. The advancement of PCR technology and the fostering of a dynamic market environment are being fueled by government support for research and development activities. A growing emphasis on personalized medicine is being witnessed across Europe, by which a demand for sophisticated PCR tools used in genetic analysis and tailored healthcare approaches is being created. These factors are collectively contributing to Europe's rapid growth in the PCR market, positioning it as a region where cutting-edge developments and increasing adoption of PCR technologies are being consistently observed.

Competitive Landscape

The Polymerase Chain Reaction PCR Market continues to change and evolve with innovations and also new technologies. There is a continuous promotion of new materials and the improvement of sensors. Cloud-based delivery by companies needs to meet new industry requirements and demands. The market share for polymerase chain reaction PCR is an intense and consistently evolving field where new and old players are still fighting for occupation.

Some of the key players operating in the polymerase chain reaction PCR market include:

Hoffmann-La Roche Ltd.

Thermo Fisher Scientific Inc.

Merck KGaA, Agilent Technologies, Inc.

Danaher Corporation

Bio-Rad Laboratories Inc.

QIAGEN N.V.

Abbott Laboratories

Takara Bio Inc.

Becton

Dickinson and Company

Polymerase Chain Reaction (PCR) Market Latest Developments

In October 2024, Abbott Laboratories announced that they got clearance for their Alinity mPCR System, a real-time PCR platform for clinical laboratories. This user-friendly, automated system aimed to expand PCR technology access for various diagnostic applications.

In May 2024, Thermo Fisher Scientific announced the launch of the Applied Biosystems TaqMan MiniChip PCR System, a miniaturized platform for point-of-care settings. This development addressed the market's growing interest in portable PCR solutions for rapid diagnostics in resource-limited environments.

1 INTRODUCTION OF GLOBAL POLYMERASE CHAIN REACTION (PCR) MARKET

1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL POLYMERASE CHAIN REACTION (PCR) MARKET OUTLOOK

4.1 Overview
4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis

5 GLOBAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY PRODUCT

5.1 Overview
5.2 Instruments
5.3 Reagents & Consumables

6 GLOBAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY APPLICATION

6.1 Overview
6.2 Clinical Diagnostics
6.3 Life Sciences Cloud-based

7 GLOBAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY END-USER

7.1 Overview
7.2 Clinical Diagnostics Labs
7.3 Research Institutions
7.4 Pharmaceutical Companies

8 GLOBAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY GEOGRAPHY

8.1 Overview
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
- 8.2.3 Mexico
8.3 Europe
- 8.3.1 Germany
- 8.3.2 U.K.
- 8.3.3 France
- 8.3.4 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Rest of Asia Pacific
8.5 Rest of the World
- 8.5.1 Latin America
- 8.5.2 Middle East & Africa

9 GLOBAL POLYMERASE CHAIN REACTION (PCR) MARKET COMPETITIVE LANDSCAPE

9.1 Overview
9.2 Company Market Ranking
9.3 Key Development Strategies

10 COMPANY PROFILES

10.1 Hoffmann-La Roche Ltd.
- 10.1.1 Overview
- 10.1.2 Financial Performance
- 10.1.3 Product Outlook
- 10.1.4 Key Developments
10.2 Thermo Fisher Scientific Inc.
- 10.2.1 Overview
- 10.2.2 Financial Performance
- 10.2.3 Product Outlook
- 10.2.4 Key Developments
10.3 Merck KGaA, Agilent Technologies, Inc.
- 10.3.1 Overview
- 10.3.2 Financial Performance
- 10.3.3 Product Outlook
- 10.3.4 Key Developments
10.4 Danaher Corporation
- 10.4.1 Overview
- 10.4.2 Financial Performance
- 10.4.3 Product Outlook
- 10.4.4 Key Developments
10.5 Bio-Rad Laboratories Inc.
- 10.5.1 Overview
- 10.5.2 Financial Performance
- 10.5.3 Product Outlook
- 10.5.4 Key Developments
10.6 QIAGEN N.V.
- 10.6.1 Overview
- 10.6.2 Financial Performance
- 10.6.3 Product Outlook
- 10.6.4 Key Developments
10.7 Abbott Laboratories
- 10.7.1 Overview
- 10.7.2 Financial Performance
- 10.7.3 Product Outlook
- 10.7.4 Key Developments
10.8 Takara Bio Inc.
- 10.8.1 Overview
- 10.8.2 Financial Performance
- 10.8.3 Product Outlook
- 10.8.4 Key Developments
10.9 Becton
- 10.9.1 Overview
- 10.9.2 Financial Performance
- 10.9.3 Product Outlook
- 10.9.4 Key Developments
10.10 Dickinson and Company
- 10.10.1 Overview
- 10.10.2 Financial Performance
- 10.10.3 Product Outlook
- 10.10.4 Key Developments

11 Appendix

11.1 Related Research

02-2729-4219

+886-2-2729-4219

License/价格

2026 年至 2032 年聚合酵素链锁反应(PCR) 市场（按产品、应用、最终用户和地区）